TITAN installed and running at Fusion Antibodies laboratory

Causeway Sensors and Fusion Antibodies staff with the TITAN bioprocess monitor system in the Fusion Antibodies laboratory.

Fusion Antibodies are testing the Causeway Sensors TITAN biosensor system as part of our Innovate UK funded project to strengthen the regional ability to manufacture the complex building blocks required for modern medicines production.

TITAN has already returned stellar data that has aided in process decisions and Antony Murphy, CEO of Causeway Sensors, commented, "TITAN has again proven its ability to produce timely, informative titre data, allowing those in charge of bioproduction lines to make better decisions and keep a better handle on these complex processes. Fusion Antibodies have been a delight to work with and we look forward to even more high quality data from our joint research."